Tnfaip2 promotes atherogenesis by enhancing oxidative stress induced inflammation.

The inflammation is considered to be the crucial determinants of lesion progression and plaque stability during atherogenesis. Tnfaip2 appears to be a regulator for carcinogenesis and infectious diseases. But its role in atherosclerosis is not clear.